RemeGen Co., Ltd. (SHA:688331)
China
· Delayed Price · Currency is CNY 43.97
+3.12 (7.64%)
Apr 1, 2025, 2:45 PM CST
RemeGen Revenue
In the year 2024, RemeGen had annual revenue of 1.72B CNY with 58.40% growth. RemeGen had revenue of 506.53M in the quarter ending December 31, 2024, with 61.58% growth.
Revenue
1.72B
Revenue Growth
+58.40%
P/S Ratio
n/a
Revenue / Employee
474.52K
Employees
3,615
Market Cap
20.05B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 26.00B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Aier Eye Hospital Group | 20.62B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Yunnan Baiyao Group Co.,Ltd | 39.34B |
| Shanghai United Imaging Healthcare | 10.30B |
| Sichuan Biokin Pharmaceutical | 5.82B |